ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Apotex Recalls Enoxaparin Sodium Injection americanpharmaceuticalreview
February 10, 2021Apotex is voluntarily recalling two batches of Enoxaparin Sodium Injection, USP to consumer level due to a packaging error resulting in some syringes barrels containing 150 mg/mL markings (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL ...
Pharma Sources Insight January 2025
